|
Oct 10
|
Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook
|
|
Oct 9
|
Fagron SA (ARSUF) Q2 2024 Earnings Call Highlights: Strong Growth and Upgraded Revenue Guidance
|
|
Aug 30
|
Fagron’s share buy-back program: Weekly update
|
|
May 13
|
Fagron shareholders approve all voting items at AGM and EGM
|
|
Jan 8
|
Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold
|
|
Sep 8
|
Progress share buy-back program Fagron
|